Cardinal Health, Inc. operates as a key player in the integrated healthcare services landscape, providing solutions that span from pharmaceutical distribution to medical product manufacturing. With a robust presence across multiple regions, Cardinal Health remains a pivotal figure in fulfilling healthcare needs worldwide. The stock's current ratings demonstrate a stable position, though ongoing observation is recommended.
The fundamental analysis shows a balanced evaluation of the company's performance metrics.
| Category | Score | Visualization |
|---|---|---|
| Overall | 2 | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 1 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
The historical data provides insights into the stock's performance and recent changes.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-23 | 2 | 5 | 1 | 4 | 1 | 2 | 1 |
| Previous | 0 | 5 | 1 | 4 | 1 | 2 | 1 |
The projected price targets indicate a positive outlook from analysts.
| High | Low | Median | Consensus |
|---|---|---|---|
| $189 | $150 | $181 | $177 |
The sentiment from analysts showcases a tendency towards buying recommendations.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 16 | |
| Sell | 0 | |
| Strong Sell | 0 |
Cardinal Health, Inc. maintains a firm standing in the healthcare distribution industry. The company's mixed fundamental scores highlight areas for growth, specifically in equity management. Positive analyst sentiment and solid historical ratings suggest a stable investment potential, although potential investors should consider monitoring broader market conditions. Overall, the stock presents a moderate risk with promising returns on the strength of its core operations.